Spyros Papapetropoulos - 11 Apr 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Director
Signature
/s/ Spyros Papapetropoulos
Issuer symbol
LPCN
Transactions as of
11 Apr 2022
Net transactions value
+$11,600
Form type
4
Filing time
12 Apr 2022, 17:00:09 UTC
Previous filing
03 Mar 2022
Next filing
04 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $11,600 +10,000 $1.16 10,000 11 Apr 2022 Common Stock 10,000 $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of April 11, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.